Corpus StriatumDopamineReceptors, Dopamine D2Receptors, DopamineDopamine AntagonistsReceptors, Dopamine D1RacloprideDopamine AgonistsReceptors, Dopamine D3BrainDopamine AgentsSalicylamides3,4-Dihydroxyphenylacetic Acidalpha-MethyltyrosineDopamine Plasma Membrane Transport ProteinsDomperidoneSubstantia NigraApomorphineBerberineDopamine Uptake InhibitorsCorpus LuteumBenzazepinesNeostriatumRats, Sprague-DawleySulpirideCorpus CallosumNeuronsReceptors, Dopamine D5PutamenHaloperidolRats, Inbred StrainsOxidopamineTyrosine 3-MonooxygenaseDopamine beta-HydroxylaseCarbon RadioisotopesPositron-Emission TomographyAgenesis of Corpus CallosumClozapineQuinpirolePyrrolidinesNucleus AccumbensBasal Ganglia Diseases2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepineCocaineHomovanillic AcidAmphetamineLevodopaMicrodialysisDopamine and cAMP-Regulated Phosphoprotein 32Dopaminergic NeuronsBasal GangliaCaudate NucleusTomography, Emission-ComputedSpiperoneMesencephalonBehavior, AnimalRewardVentral Tegmental AreaErgolinesMotor ActivityNomifensineMethamphetamineDihydroxyphenylalanineTropanesBiogenic MonoaminesParkinsonian DisordersVesicular Monoamine Transport ProteinsFlupenthixolCorpora AllataParkinson Disease, SecondaryDose-Response Relationship, DrugBromocriptineSerotoninPrefrontal CortexStereotyped BehaviorCentral Nervous System StimulantsNerve Tissue ProteinsBrain Chemistry1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineNeural PathwaysAnalysis of VarianceMedial Forebrain BundleLimbic SystemRats, WistarMPTP PoisoningButaclamolDyskinesia, Drug-InducedAntiparkinson AgentsPenisNorepinephrineSynaptosomesTime FactorsConditioning, OperantDextroamphetamineReserpineAntipsychotic AgentsSynaptic TransmissionHydroxydopaminesCorpus Luteum MaintenanceSelf Administration